FI942442A0 - Proteiinien tuotto 7B2-proteiinia käyttäen - Google Patents

Proteiinien tuotto 7B2-proteiinia käyttäen

Info

Publication number
FI942442A0
FI942442A0 FI942442A FI942442A FI942442A0 FI 942442 A0 FI942442 A0 FI 942442A0 FI 942442 A FI942442 A FI 942442A FI 942442 A FI942442 A FI 942442A FI 942442 A0 FI942442 A0 FI 942442A0
Authority
FI
Finland
Prior art keywords
protein
pct
expressing
vivo
sec
Prior art date
Application number
FI942442A
Other languages
English (en)
Swedish (sv)
Other versions
FI942442A (fi
Inventor
Gerardus Julianus Mari Martens
Bhabatosh Chaudhuri
Christine Stephan
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI942442A0 publication Critical patent/FI942442A0/fi
Publication of FI942442A publication Critical patent/FI942442A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI942442A 1991-11-29 1994-05-25 Proteiinien tuotto 7B2-proteiinia käyttäen FI942442A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9102009A NL9102009A (nl) 1991-11-29 1991-11-29 Produktie van bioactieve peptiden met recombinante cellen.
PCT/EP1992/002740 WO1993011248A1 (en) 1991-11-29 1992-11-27 Production of proteins using 7b2 protein

Publications (2)

Publication Number Publication Date
FI942442A0 true FI942442A0 (fi) 1994-05-25
FI942442A FI942442A (fi) 1994-07-25

Family

ID=19859984

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942442A FI942442A (fi) 1991-11-29 1994-05-25 Proteiinien tuotto 7B2-proteiinia käyttäen

Country Status (11)

Country Link
US (2) US5708140A (fi)
EP (1) EP0614490B1 (fi)
JP (1) JPH07501448A (fi)
AT (1) ATE174629T1 (fi)
AU (1) AU675919B2 (fi)
CA (1) CA2123567A1 (fi)
DE (1) DE69227921D1 (fi)
FI (1) FI942442A (fi)
HU (1) HUT67739A (fi)
NL (1) NL9102009A (fi)
WO (1) WO1993011248A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025681A1 (en) * 1992-06-11 1993-12-23 New York University A cytoplasmic chaperonin and methods of making and using it
US5474914A (en) * 1992-07-29 1995-12-12 Chiron Corporation Method of producing secreted CMV glycoprotein H
DK0663010T3 (da) * 1992-10-02 2000-11-13 Res Corp Technologies Inc Fremgangsmåde til forøgelse af sekretion af overudtrykte proteiner
GB9223816D0 (en) 1992-11-13 1993-01-06 Medical Res Council Heat shock proteins and the treatment of tumours
US5688651A (en) * 1994-12-16 1997-11-18 Ramot University Authority For Applied Research And Development Ltd. Prevention of protein aggregation
JPH09173078A (ja) * 1995-09-14 1997-07-08 Tadayuki Imanaka 分子シャペロンを用いる蛋白質の製造方法
US6294661B1 (en) * 1996-05-14 2001-09-25 Smithkline Beecham Corporation Compounds
AU5602100A (en) 1999-06-09 2000-12-28 Arch Development Corporation Recombinant prion-like genes and proteins and materials and methods comprising same
EP1409709A2 (en) * 2000-05-03 2004-04-21 Expressive Constructs, Inc. A method for improving recombinant protein stability and solubility
JP4528460B2 (ja) * 2000-06-30 2010-08-18 株式会社東芝 半導体素子
US20040138116A1 (en) * 2002-08-30 2004-07-15 Vincent Geenen Tolerogenic approach for type 1 diabetes
EP1624886A2 (en) * 2003-05-12 2006-02-15 Expressive Constructs, Inc. Methods for increasing cell and tissue viability
US20050261475A1 (en) * 2004-02-13 2005-11-24 Harvard Medical School Solid-phase capture-release-tag methods for phosphoproteomic analyses
FR3008713B1 (fr) * 2013-07-18 2016-11-25 Commissariat Energie Atomique Procede d'extraction et de purification d'acides nucleiques et tampons mis en œuvre

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8702590A (nl) * 1987-10-30 1989-05-16 Stichting Katholieke Univ Eiwit 7b2 alsmede recombinant dna en cdna, mrna, en antilichamen voor 7b2 en werkwijze voor het detecteren van 7b2.
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells

Also Published As

Publication number Publication date
NL9102009A (nl) 1993-06-16
CA2123567A1 (en) 1993-06-10
WO1993011248A1 (en) 1993-06-10
HU9401604D0 (en) 1994-09-28
EP0614490B1 (en) 1998-12-16
EP0614490A1 (en) 1994-09-14
AU675919B2 (en) 1997-02-27
ATE174629T1 (de) 1999-01-15
FI942442A (fi) 1994-07-25
DE69227921D1 (de) 1999-01-28
US5804417A (en) 1998-09-08
JPH07501448A (ja) 1995-02-16
US5708140A (en) 1998-01-13
HUT67739A (en) 1995-04-28
AU2946192A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
FI942442A0 (fi) Proteiinien tuotto 7B2-proteiinia käyttäen
DE69434447D1 (de) Für die gentherapie verwendbare plasmide
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DE69323879D1 (de) Herstellung von rekombinanten, menschlichem lactoferrin
DE3852823D1 (de) Transduktionsveränderte fibroblasten und ihre anwendung.
DE69410254T2 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
DE69432075T2 (de) Intrazellulaere bindungs proteine und deren anwendungen
ES2193144T3 (es) Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa.
ATE175237T1 (de) Polypeptide beteiligt an der kobalamin- und/oder kobamid-biosynthese, für diese kodierende dns- sequencen, und ihre herstellung und vewendung.
NO971139D0 (no) Fremgangsmåte for fremstilling av rekombinante proteiner, plasmider og modifiserte celler
AU669149B2 (en) Expression signal-peptide-free staphylokinases
ATE315091T1 (de) Modifizierte zellen auf der basis des betain- katabolismus, herstellung und verwendung insbesondere zur herstellung von metaboliten oder enzymen
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
DE69132682T2 (de) Zellwachstumsinhibitoren
DE69728654D1 (de) Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus
DE69133340D1 (de) Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen
ATE123056T1 (de) Ancrod-proteine, ihre herstellung und verwendung.
DE69916829D1 (de) Genetisch veränderte fibroblasten und ihre verwendung
DE69434072D1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
ATE113314T1 (de) Genetisch modifizierte milchsäurebakterien und ihre verwendung bei der herstellung von käse und rekombinanten plasmiden.
AU5110390A (en) Cdna coding for placental protein 9 (pp9), the isolation and use thereof
AU674909B2 (en) New triazoloquinazolines, their production and their use
EP0374909A3 (de) Für das Plazentaprotein 11 (PP11) kodierende cDNA, ihre Isolierung und Verwendung
ATE32066T1 (de) Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl und -sulfinyl-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG